Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
3,92 AUD | +5,95% | +40,00% | +106,32% |
Attività
Numero di dipendenti: 41
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Colin Biggin
CEO | Chief Executive Officer | - | 01/01/17 |
Matthew Harris
FOU | Founder | - | 01/01/10 |
David Green
DFI | Director of Finance/CFO | - | 01/01/22 |
Shaemus Gleason
COO | Chief Operating Officer | - | 01/05/21 |
Chief Tech/Sci/R&D Officer | - | 13/09/22 | |
Ellen van Dam
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/14 |
Michelle Parker
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/18 |
Catherine Strong
IRC | Investor Relations Contact | - | - |
Mike Ironside
PRN | Corporate Officer/Principal | - | 01/06/20 |
General Counsel | - | 01/10/19 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chris Roberts
BRD | Director/Board Member | 70 | - |
Robert Thomas
BRD | Director/Board Member | 79 | 25/08/21 |
Thomas Ramdahl
BRD | Director/Board Member | 68 | - |
Matthew Harris
FOU | Founder | - | 01/01/10 |
Alan Taylor
CHM | Chairman | - | - |
Director/Board Member | - | - | |
Colin Biggin
CEO | Chief Executive Officer | - | 01/01/17 |
David Green
DFI | Director of Finance/CFO | - | 01/01/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 271 098 503 | 219 254 543 ( 80,88 %) | 0 | 80,88 % |
Coordinate società
Clarity Pharmaceuticals Ltd.
National Innovation Centre 4 Cornwallis Street
2015, Eveleigh
+
http://www.claritypharmaceuticals.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+106,32% | 760 Mln | |
+3,99% | 106 Mrd | |
+7,02% | 23,47 Mrd | |
-14,51% | 21,9 Mrd | |
-7,05% | 18,77 Mrd | |
-38,55% | 17,85 Mrd | |
-8,69% | 16,78 Mrd | |
+6,59% | 14,41 Mrd | |
+34,97% | 12,86 Mrd | |
+317,28% | 8,78 Mrd |
- Borsa valori
- Azioni
- Azione CU6
- Società Clarity Pharmaceuticals Ltd